Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA to publish MRA (mutual recognition agreement) expansion proposal "within weeks"

This article was originally published in Clinica

Executive Summary

The European Commission has welcomed the US FDA's proposal to significantly expand the list of products eligible for inclusion in the EU/US mutual recognition agreement (MRA) and to include in vitro diagnostic products. European industry has generally been unenthusiastic about the trade agreement because of the small number of devices (97) included and has long been pushing for a broader scope (see Clinica No 943, p 3).





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts